EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 10th, 2016 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is effective as of June 16, 2016 (the “Effective Date”), by and between Dan Adelman (“Executive”) and Aimmune Therapeutics, Inc. (the “Company”).
SEPARATION AGREEMENTSeparation Agreement • August 10th, 2016 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
This Separation Agreement (the “Agreement”) by and between Robert M. Elfont, M.D., Ph.D. (“Executive”), and Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective as of the eighth (8th) day following the date Executive signs this Agreement if not revoked in accordance with Section 6(c)(iii) (the “Effective Date”) with reference to the following facts:
AMENDMENT TO LEASE BY AND BETWEEN MYERLAKE, LLC. AND AIMMUNE THERAPEUTICS, INC. DATED JUNE 8, 2015Lease Amendment • August 10th, 2016 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT (“Amendment”) is made this 5th day of May, 2016, by and between MYERLAKE, LLC., a Florida limited liability company ("Landlord"), and AIMMUNE THERAPEUTICS, INC., a Delaware corporation, ("Tenant"), and is attached to and made a part of the Lease between the parties dated June 8, 2015 (the "Lease").
